Shuttle Pharmaceuticals ...

0.55
-0.06 (-9.66%)
At close: Mar 03, 2025, 3:59 PM
0.56
2.67%
After-hours: Mar 03, 2025, 06:10 PM EST

Shuttle Pharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY18 FY17
Cash & Equivalents 1.92B 2.58M 8.42M 504.75K 117.15K 352.39K 50.71K
Short-Term Investments n/a 2.89M n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a 6.48K 6.48K 6.48K 6.48K n/a
Receivables n/a 14.9K n/a n/a 211.46K 3.83K 49.21K
Inventory n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 290.77M 114.47K 161.15K 4.87K 12.58K 257.74K 2.54K
Total Current Assets 2.21B 5.59M 8.58M 509.62K 341.19K 613.96K 102.46K
Property-Plant & Equipment 295.37M 358.73K 68.71K 135.55K 196.38K 838.00 18.84K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 295.37M 358.73K 75.19K 142.03K 202.86K 7.32K 18.84K
Total Assets 2.51B 5.95M 8.65M 651.64K 544.05K 621.27K 121.3K
Account Payables n/a 283.31K 129.25K 828.31K 516.97K 30.73K 79.1K
Deferred Revenue n/a n/a n/a 378.56K 228.39K 17.54K n/a
Short-Term Debt 1.41B 648.48K 811.12K 916.43K 686.44K 400K 314.38K
Other Current Liabilities 120.27M 110.45K 35.31K 472.58K 901.56K 145.54K 12.16K
Total Current Liabilities 1.53B 1.04M 975.68K 2.22M 2.1M 593.82K 405.65K
Long-Term Debt 238.09M 439.22K n/a 62.44K 129.38K n/a n/a
Other Long-Term Liabilities 25.28M 414.51K n/a n/a n/a n/a n/a
Total Long-Term Liabilities 263.37M 853.73K 865.04K 62.44K 129.38K n/a n/a
Total Liabilities 1.8B 1.9M 975.68K 2.28M 2.23M 593.82K 405.65K
Total Debt 1.65B 1.09M 748.3K 978.88K 815.82K 400K 314.38K
Common Stock 41K 20.00 136.00 93.00 93.00 179.00 450K
Retained Earnings -34.58B -25.43M -8.89M -5.8M -4.54M -1.91M -1.28M
Comprehensive Income n/a n/a n/a 16.34K 16.34K 16.34K n/a
Shareholders Equity 709.15M 4.06M 7.68M -1.63M -1.69M 27.46K -284.35K
Total Investments n/a 2.89M n/a n/a n/a n/a n/a